Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

NCT05691517 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: pH Low Insertion Peptide-exatecan Conjugate CBX-12

Sponsor

National Cancer Institute (NCI)